X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs NATCO PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA NATCO PHARMA FULFORD INDIA/
NATCO PHARMA
 
P/E (TTM) x 398.8 19.3 2,061.5% View Chart
P/BV x 6.2 18.5 33.6% View Chart
Dividend Yield % 0.1 0.6 13.7%  

Financials

 FULFORD INDIA   NATCO PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
NATCO PHARMA
Mar-14
FULFORD INDIA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs942877 107.4%   
Low Rs450424 106.3%   
Sales per share (Unadj.) Rs691.4223.4 309.4%  
Earnings per share (Unadj.) Rs11.531.1 36.9%  
Cash flow per share (Unadj.) Rs15.440.3 38.1%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Dividend yield (eoy) %0.30.8 37.4%  
Book value per share (Unadj.) Rs380.0219.5 173.1%  
Shares outstanding (eoy) m3.9033.07 11.8%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x1.02.9 34.6%   
Avg P/E ratio x60.720.9 290.1%  
P/CF ratio (eoy) x45.316.1 280.7%  
Price / Book Value ratio x1.83.0 61.8%  
Dividend payout %17.416.1 108.4%   
Avg Mkt Cap Rs m2,71421,504 12.6%   
No. of employees `0000.4NA-   
Total wages/salary Rs m5051,128 44.8%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,6967,389 36.5%  
Other income Rs m125167 75.0%   
Total revenues Rs m2,8227,556 37.3%   
Gross profit Rs m-461,793 -2.6%  
Depreciation Rs m15304 5.0%   
Interest Rs m10366 2.6%   
Profit before tax Rs m541,290 4.2%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10309 3.1%   
Profit after tax Rs m451,027 4.4%  
Gross profit margin %-1.724.3 -7.1%  
Effective tax rate %17.723.9 73.9%   
Net profit margin %1.713.9 11.9%  
BALANCE SHEET DATA
Current assets Rs m1,7383,681 47.2%   
Current liabilities Rs m5453,123 17.4%   
Net working cap to sales %44.37.6 585.6%  
Current ratio x3.21.2 270.7%  
Inventory Days Days4889 54.2%  
Debtors Days Days459 7.3%  
Net fixed assets Rs m127,685 0.2%   
Share capital Rs m39331 11.8%   
"Free" reserves Rs m1,4436,670 21.6%   
Net worth Rs m1,4827,259 20.4%   
Long term debt Rs m0955 0.0%   
Total assets Rs m2,07711,957 17.4%  
Interest coverage x6.74.5 148.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.6 210.1%   
Return on assets %2.611.7 22.4%  
Return on equity %3.014.2 21.3%  
Return on capital %4.320.7 20.8%  
Exports to sales %039.4 0.0%   
Imports to sales %24.55.7 428.9%   
Exports (fob) Rs mNA2,908 0.0%   
Imports (cif) Rs m659421 156.5%   
Fx inflow Rs m173,445 0.5%   
Fx outflow Rs m673703 95.8%   
Net fx Rs m-6562,743 -23.9%   
CASH FLOW
From Operations Rs m901,440 6.2%  
From Investments Rs m105-1,089 -9.6%  
From Financial Activity Rs m-14-353 4.0%  
Net Cashflow Rs m181-1 -12,114.1%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 1.5 5,102.0%  
Indian inst/Mut Fund % 3.8 7.8 48.5%  
FIIs % 0.1 16.6 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 26.0 81.5%  
Shareholders   4,783 25,395 18.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PLETHICO PHARMA  

Compare FULFORD INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Idea Cellular Plunges 6%(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally below the dotted line.

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 69.6%

May 25, 2018 | Updated on May 25, 2018

For the quarter ended March 2018, NATCO PHARMA has posted a net profit of Rs 3 bn (up 69.6% YoY). Sales on the other hand came in at Rs 8 bn (up 32.9% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS